Location
United States, North America
Cheque size
$500K - $15M
Investment Stage
Series A
Series B
Focus Areas
Health & Hospital Services
BioTech
AgTech
Food and Beverage
About Investor
Douglas Cole is Managing Partner at Flagship Pioneering, where he has been since 2001 and focuses on life science. At Flagship, he has co-founded companies including Moderna, Foghorn Therapeutics, Ensemble Therapeutics, Inzen Therapeutics, Sigilon Therapeutics, and Syros Pharmaceuticals. Cole trained in medicine at Johns Hopkins Hospital and in neurology at Massachusetts General Hospital after earning his M.D. from the University of Pennsylvania School of Medicine.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,NP
Neil Peet
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.